Up | AC
Subcommittee of the Oncologic Drugs Advisory Committee
June 27, 2007
this document have been determined to be exempt from disclosure under the
Freedom of Information Act (the FOIA) (5 U.S.C. § 552). These redacted portions
will appear as white space on the screen or on the printed page.
Briefing Material (pdf)